Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mustang Bio, Inc

3.63
+2.44205.04%
Volume:252.99M
Turnover:1.29B
Market Cap:15.89M
PE:-0.14
High:7.00
Open:3.57
Low:3.35
Close:1.19
Loading ...

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

Dow Jones
·
Yesterday

BUZZ-Mustang soars on FDA's orphan drug tag for brain cancer therapy

Reuters
·
13 mins ago

BUZZ-U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock

Reuters
·
49 mins ago

Mustang Bio granted orphan drug designation by FDA for MB-101

TIPRANKS
·
Yesterday

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for Mb-101 (Il13ra2-Targeted Car T-Cells) to Treat Astrocytomas and Glioblastoma

THOMSON REUTERS
·
Yesterday

Wall Street Set to Open Lower Wednesday as Jobs Data Misses Forecasts

MT Newswires Live
·
02 Jul

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

GlobeNewswire
·
06 Mar

Wall Street Set to Open Higher Friday as Inflation Data Meets Expectations

MT Newswires Live
·
28 Feb

Mustang Bio exits lease for Massachusetts facility, divests equipment

TIPRANKS
·
28 Feb

Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility

Dow Jones
·
28 Feb

Mustang Bio Inc - to Initiate Clinical Trial With Mb-109 for GBM in H2 2025

THOMSON REUTERS
·
28 Feb

Mustang Bio Inc - Exits Lease for Worcester Facility, Divests Assets to Abbvie for $1 Mln

THOMSON REUTERS
·
28 Feb

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

THOMSON REUTERS
·
28 Feb

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

GlobeNewswire
·
28 Feb

BRIEF-Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie

Reuters
·
14 Feb

Mustang Bio Inc - Abbvie to Purchase Ff&E From Mustang Bio for $1 Million

THOMSON REUTERS
·
14 Feb

Mustang Bio regains compliance with Nasdaq

TIPRANKS
·
12 Feb

Mustang Bio Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
12 Feb

Mustang Bio Announces Closing of $8 Million Public Offering

THOMSON REUTERS
·
10 Feb

Mustang Bio Announces Closing of $8 Million Public Offering

GlobeNewswire
·
10 Feb